1 Product identity
Ingredient risk
No flagged ingredients
Total Heart II
BrandNutri-West→Other Combinations Tablet or Pill 8 ingredients DSLD #28493Net contents: 90 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-12-24
2 Ingredients (8)
IngredientGroupSafety
Co-Enzyme Q-10Coenzyme Q-10—
HeartHeart—
SpleenSpleen—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Vitamin C — Limited Evidence
⚠ GI distress at high doses
⚠ Kidney stones risk >1g/day
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Folate — Conditionally Safe
⚠ May mask B12 deficiency
⚠ Colorectal cancer risk debated
L-Carnitine — Generally Safe
⚠ Fishy body odor
⚠ TMAO concern
Glycine — Limited Evidence
⚠ Well tolerated
4 Label claims
• All Other
5 Data source
DSLD ID28493
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-12-24
6 More from Nutri-West
View Nutri-West Safety Scorecard → 186 products
#1 - AD#2 - CFAdreno - Lyph - SymAdreno-Lyph 80Adreno-Lyph-160Adreno-Lyph-Para7 Cite this page
Vancouver
Pkhakadze G. Total Heart II — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 30]. Available from: https://supplement.ge/products/total-heart-ii-28493/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG